Table 5.

Drug and Sex Related Risk Reduction or Low Risk Maintenance Among RAP Participants from Baseline to 6-month Follow-up, Prior 30 Day Reported Behavior (percentages who completed both surveys, n=367)

	PHAs (n=98)		CRs (n=157)		Others (n=102) a		Total (n=367) b
	n	(%)	n	(%)	n	(%)	n	(%)
Non-injector at baseline:	(59)	(60.2)	(102)	(65.0)	(53)	(52.0)	(220)	(59.9)
Remained non-injector at 6-mo.	58	98.3 c	97	95.1 c	50	94.3 c	210	95.5 c
Injector at baseline:	(39)	(39.8)	(55)	(35.0)	(49)	(48.0)	(147)	(40.1)
Ceased all injection at follow-up	18	46.2 d	14	25.5 d	22	49.9 d	55	37.4 d
Ceased or reduced injection rate	30	76.9 d	40	72.7 d	37	75.5 d	109	74.1 d
Ceased or reduced sharing syringes or       continued non-sharing	38	97.4 e	54	98.2 e	45	91.8 e	141	95.9 e
Ceased or reduced sharing injection works       or continued non-sharing	36	97.3 e	49	89.1 e	44	89.8 e	133	91.7 e
Ceased or reduced sharing drug solutions or       continued non-sharing	35	94.6 e	50	90.9 e	46	93.9 e	135	93.1 e
Non-crack user at baseline:	(33)	(33.7)	(61)	(38.9)	(51)	(50.0)	(149)	(40.6)
Remained non-crack user at follow-up	31	93.9 f	51	83.6 f	39	76.5 f	123	82.6 f
Crack user at baseline:	(65)	(66.3)	(96)	(61.1)	(51)	(50.0)	(218)	(59.4)
Ceased all crack use at follow-up	28	43.1 g	32	33.3 g	18	35.3 g	79	36.2 g
Ceased or reduced rate of crack use	47	72.3 g	68	70.8 g	31	60.8 g	149	68.3 g
Initiated or increased use of rubber tips	29	70.7 h	38	56.7 h	21	63.6 h	90	61.2 h
Sexually active at baseline:	(75)	(76.5)	(112)	(72.3)	(72)	(70.6)	(266)	(72.9)
Reduced number of sex partners	38	50.7 i	36	32.1 i	34	47.2 i	112	41.7 i
Ceased or reduced all unprotected sex or       continued no unprotected sex	55	74.3 i	81	73.6 i	59	81.9 i	200	76.3 i
Ceased or reduced unprotected sex with       primary partner	55	75.3 i	84	76.4 i	59	83.1 i	198	78.0 i
Ceased or reduced unprotected sex with       non-primary partner	73	100.0 i	103	93.6 i	69	97.2 i	251	96.5 i
Ceased or reduced unprotected sex in       exchange for money/drugs*	73	100.0 i	101	91.8 i	67	94.4 i	247	95.0 i
Ceased all sexual activity	18	24.0 i	19	17.0 i	18	25.0 i	55	20.7 i

^aIncludes 76 CRs of all untrained PHAs (i.e., those who attended 0–4 training sessions) and 26 PHAs who never started the training; PHAs who attended 1–4 training sessions are excluded from this group.

^bTen PHAs who attended only 1–4 sessions were included in the follow-up total.

^cCalculated as percent of participants who were non-injectors at baseline.

^dCalculated as percent of participants who were injectors at baseline.

^eCalculated as percent of participants who were injectors at either baseline or follow-up.

^fCalculated as percent of participants who were non-crack users at baseline.

^gCalculated as percent of participants who were crack users at baseline.

^hCalculated as percent of participants who smoked crack in the prior 6 months before both surveys.

ⁱCalculated as percent of participants who had sex in the last 30 days before the baseline surveys.

^*Differences in the comparison between PHAs and all other participants combined (CRs plus Others) were statistically significant (p < .05).